AIT Therapeutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beyond Air Inc (XAIR)
Beyond Air Inc stock price live, this page displays NASDAQ XAIR stock exchange data. View the XAIR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beyond Air Inc real time stock price chart below.
What Is the Beyond Air Inc Stock Price Today?
The Beyond Air Inc stock price today is 3.320.
What Is the Stock Symbol for Beyond Air Inc?
The stock symbol for Beyond Air Inc is ""XAIR.""
What Stock Exchange Does Beyond Air Inc Trade On?
Beyond Air Inc is listed and trades on the NASDAQ stock exchange.
Is Beyond Air Inc a Good Stock to Buy?
Determining whether Beyond Air Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XAIR quote. (ISIN: US08862L2025)
What Is the Beyond Air Inc Stock Price Today?
The Beyond Air Inc stock price today is 3.320.
What Is the Stock Symbol for Beyond Air Inc?
The stock symbol for Beyond Air Inc is ""XAIR.""
What Stock Exchange Does Beyond Air Inc Trade On?
Beyond Air Inc is listed and trades on the NASDAQ stock exchange.
Is Beyond Air Inc a Good Stock to Buy?
Determining whether Beyond Air Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XAIR quote. (ISIN: US08862L2025)
3.320
-0.040(-1.19%)
Closed·
After Hours
3.378+0.058(+1.75%)
·
Fair Value
An estimate of a Beyond Air's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.295
3.470
52 wk Range
2.900
13.522
XAIR Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 13 days
More Info
Fair Value
An estimate of a Beyond Air's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2953.470
52 wk Range
2.90013.522
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XAIR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Beyond Air's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
36.600
Upside
+1,002.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Beyond Air Inc Company Profile
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Beyond Air Inc SWOT Analysis
Innovative NO Delivery | Beyond Air's LungFit PH system generates nitric oxide from room air, potentially disrupting the $700 million global market for NO delivery systems |
Financial Hurdles | Explore Beyond Air's strategy to overcome significant cash burn and reach cash flow breakeven by fiscal year 2027, despite lowered revenue projections |
Market Expansion Plans | Learn about Beyond Air's efforts to expand LungFit PH's approved uses, including a pending FDA decision for cardiac surgeries and pursuit of CE mark in Europe |
Competitive Landscape | Delve into Beyond Air's positioning against dominant players like Mallinckrodt, with analyst price target at $2.00 amid market challenges and opportunities |
Beyond Air Inc Earnings Call Summary for Q4/2025
- EPS beat expectations at -$0.09 vs -$0.15 forecast; revenue missed at $1.15M vs $1.38M expected
- Stock surged 58.69% post-earnings; company reduced operating expenses by 58% year-over-year
- FY2026 revenue guidance set at $12M-$16M; Q1 2026 projected at $1.7M, 145% YoY growth
- International expansion and LungFit PH advancements highlighted as key growth drivers
- Net loss reduced to $46.6M from $60.2M; cash burn rate remains a concern despite strong liquidity
Last Updated: 17/06/2025, 22:20
Read Full TranscriptCompare XAIR to Peers and Sector
Metrics to compare | XAIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXAIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −4.4x | −0.5x | |
PEG Ratio | −0.01 | −0.30 | 0.00 | |
Price/Book | 1.1x | 2.6x | 2.6x | |
Price / LTM Sales | 4.2x | 4.2x | 3.2x | |
Upside (Analyst Target) | - | 35.8% | 40.5% | |
Fair Value Upside | Unlock | −0.5% | 4.4% | Unlock |
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 36.600
(+1,002.41% Upside)
Earnings
Latest Release
Jun 17, 2025
EPS / Forecast
-0.09 / -0.15
Revenue / Forecast
1.15M / 1.38M
People Also Watch
FAQ
What Stock Exchange Does Beyond Air Trade On?
Beyond Air is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Beyond Air?
The stock symbol for Beyond Air is "XAIR."
What Is the Beyond Air Market Cap?
As of today, Beyond Air market cap is 15.40M.
What Is Beyond Air's Earnings Per Share (TTM)?
The Beyond Air EPS (TTM) is -13.77.
When Is the Next Beyond Air Earnings Date?
Beyond Air will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is XAIR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beyond Air Stock Split?
Beyond Air has split 2 times.
How Many Employees Does Beyond Air Have?
Beyond Air has 61 employees.
What is the current trading status of Beyond Air (XAIR)?
As of 25 Jul 2025, Beyond Air (XAIR) is trading at a price of 3.32, with a previous close of 3.36. The stock has fluctuated within a day range of 3.30 to 3.47, while its 52-week range spans from 2.90 to 13.52.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.